Oak Street ‘particularly attractive’ in current environment, says Piper Sandler

Piper Sandler analyst Jessica Tassan keeps an Overweight rating on Oak Street Health (OSH) with a $47 price target after the Wall Street Journal reported CVS Health (CVS) is closing in on the acquisition of the company for $39.00 per share or $10.5B. The analyst believes Oak Street has a "de-risked path" to profitability by fiscal 2025, and views the asset as "particularly attractive" in light of the regulatory/rate environment in Medicare Advantage.